Report on Congress: Lax research regulations endanger public safety

 

Former senior director for Global Health Security and Biodefense at the National Security Council, R. Adm. Tim Ziemer, Dr. Henry Schaffer, emeritus professor of genetics and biomath at North Carolina State University, and Dr. Richard H. Ebright, Board of Governors Professor of Chemistry and Chemical Biology at Rutgers University, weigh in on international biosecurity Feb. and April 2021. Images provided.

America may fund the next deadly pandemic because most virus research across the globe is federally funded, and incompletely regulated. It is no longer a conspiracy theory that the 2019 pandemic may have begun from a lab and a new NCBI autopsy report shows the RNA vaccines invade the entire body and questions the effectiveness of vaccinating.

 Scientific research on life-threatening organisms that can spread to humans is conducted daily and the system to report accidents, thefts, loss and misuse is voluntary. The system is called biosecurity and biodefense and Congress has not stopped the public safety threat, as the 2019 pandemic exemplified.

Congress has a history of reacting with new policies to address biological disasters. For example, in 2014 the Blue Ribbon Study Panel on Biodefense assessed gaps in policies, added improvements and the panel issues updates, but it is only policy.



One example of Congress placing a policy over a life-threatening problem was in June 2020 when the director of Global Affairs in the U.S. Department of Health and Human Services reminded Congress that the International Health Regulations had already been revised after China failed to report a 2005 SARS pandemic. The revised policy was written to improve transparency and reinforce obligations to report outbreaks.

But policies did not stop the 2019 novel coronavirus pandemic and federal funding in China for research on potential pandemic viruses continues.

No International Biosecurity System

“The framework is there” to mandate controls of research, “but part of the problem is it does not extend internationally,” R. Adm. Tim Ziemer said in his first interview since leaving the White House in June 2018.

International tactics is a skill Ziemer polished during his 30-year U.S. Navy career as commander of the Mid-Atlantic Region. He served under Presidents Bush and Obama in a historic malaria initiative saving over 6 million lives by reducing malaria by 50%. 

Former President Trump asked Ziemer to serve in the National Security Council for Global Health Security and Biodefense. Ziemer had international biosecurity goals and said they merged the four primary agencies which had biodefense protocols and created a consolidated set of objectives.

But in 2018, when John Bolton, a well-known anti-military strategist, was assigned as the new National Security Advisor, the merge was dissembled and the goal for a strong pandemic response was lost.

AUDIO link to interview with R. Admiral Tim Ziemer Feb. 2021


Research on Potential Pandemic Viruses

The U.S. Government has known potential pandemic research was not properly controlled since 2011 after lab accidents with “controlled” pathogens, but Congress still funded potential pandemic virus research under the same regulations, including coronaviruses.

Plus, the U.S. Government funded this type of research in China, which is known as the “greatest threat to democracy and freedom” since World War II, according to  John Ratcliffe, the top U.S. intelligence official, in a Dec. 2020 BBC news report.

However, a policy is only a rule and rules get broken every day.

Besides, the U.S. Government also allows the sale of Do-It-Yourself DNA modification kits. Vials of DNA and scientific elements can be purchased online.

“And if you have trouble buying it, go into a lab and steal it or go into a biology lab at Pembroke [University of North Carolina] and find a nice young lab tech, or not so young, and say, “Here’s a hundred bucks. Would you mind getting me a vial of something out of the refrigerator?” Dr. Henry Schaffer, emeritus professor of genetics and biomath at North Carolina State University (NCSU), said about preventing misuse with policies and pressure, “People steal and take bribes.”

VIDEO link to interview with Dr. Henry Schaffer of North Carolina State University  

Dr. Henry Schaffer of North Carolina State University discusses the trials of scientific research on Feb. 18, 2021 with Stephanie M. Sellers via Zoom.

Schaffer now works for NCSU installing the National Institute of Technology’s intelligence theft protective software, SP 800-171, that is required for federal funding and is familiar with research security from both the lab and technological aspects.

“I am confident [China] has in its government structure, packing shops that spend their days and nights working on trying to get into U.S. Government computer systems, corporate systems, and so on,” Schaffer said.

The opportunity for misuse of research is seen in its ability to guide vaccines, create wealth, tax exemptions, fame and to create fear and control. For example, a virus could be held as a threat to bring a country to its knees, according to Ziemer.

Public safety is also compromised when high-risk research is conducted strictly out of curiosity, according to the Board of Governors’ Professor of Chemistry and Chemical Biology at Rutgers University, Dr. Richard H. Ebright.

Public safety is compromised when potential pandemic viruses are not researched in a lab designed for the specific agent. SARS, which is the foundation of the novel coronavirus is an agent that requires at least a BSL-3 lab. A BSL-3 lab is designed to protect workers from inhaling viruses, according to the Biosafety in Microbiological and Biomedical Laboratories.

“However, all coronaviruses other than SARS-CoV-2, SARS-CoV and MERS-CoV--even bat SARS-related coronaviruses deemed to pose a clear and present danger for pandemic emergence--currently are assigned as BSL-2 pathogens. This is an inappropriately, irresponsibly, indefensibly, lax biosafety standard and urgently requires revision,” Ebright said. “Currently, have a strictly Wild West system in terms of biosafety and biosecurity.”

Moreover, there is no sufficient oversight to prevent high-risk research that will not produce new information that has potential to benefit the public in some way, such as with a cure or a vaccine, according to Ebright, who said the biosecurity system is deficient because it lacks oversight and it should be international.


Check out the interactive infograph titled Throwing money at a dead horse.


“If you have a system of guidelines that is not enforced and for which there are no enforcement measures and no sanctions, when someone is out of compliance, that system of guidance will be ignored, and that is clearly what has been happening in biosafety in the U.S. and China,” Ebright said.

In 2003, Taipei and Singapore lab researchers were infected with SARS and in 2004, Beijing had two infected. The WHO advised inventory checks, meetings on policies and attending WHO safety workshops. That was almost 16 years before the 2019 pandemic and the U.S. Government, which funds virus research across the globe, continues to let risky research be self-reported, conducted without beneficial purposes, and in the hands of those deemed a threat.

The 2019 Annual Report of the Federal Select Agent Program contains a 31-page explanation of scientific research incidents and the theft, loss and release, which includes being bitten by an infected lab animal, of biological select agents and toxins (BSAT) such as coronaviruses, anthrax and H5N1.

In 2019, there were 247 labs registered to handle BSAT and of those, 189 were inspected.

There were 219 reports of BSAT release. Most of the release problems originated from defects in personal protection equipment, such as tiny holes in gowns and ill-fitting helmets. Other problems were from equipment designed to protect from infectious aerosols, and there are nine reports of BSAT loss from labs in 2019 still pending FBI determination.


Nine reports BSAT loss from labs in 2019 is still pending FBI determination.


Ebright said the biosecurity system is lax and “as a basic rule of thumb we have not let medical doctors regulate themselves,” but for biological research, they regulate themselves.

The Investigation into Origins of the Novel Coronavirus

Investigations into the origins of the novel coronavirus continue. Look at the relationships of these agencies and people and decide if they are compromised.

Dr. Peter Daszak, president of EcoHealth Alliance, has worked as a famous zoonotic disease expert with China’s Wuhan Institute of Virology, which is federally funded for gain-of-function research by the U.S. Government, for over 15 years.

Daszak’s federal funding was cut after the pandemic began and later restored when Daszak began investigating the origins of the novel coronavirus with the World Health Organization (WHO).

It is interesting to note that China’s Wuhan Institute of Virology gave the University of North Carolina at Chapel Hill’s (UNC-CH) researchers, who worked in Dr. Ralph Baric’s lab, the horseshoe bat CoV sequences to create their SARS-like virus.

And as early as 2016, Baric and his team released a study titled, “SARS-like WIV1-CoV poised for human emergence,” and it stated more vaccine research was needed.

This research was conducted during a U.S. Government moratorium on infectious disease research. Under the moratorium, gain-of-function research would not receive funding but research in progress would not be cut or stopped, and neither would vaccine research, such as Baric’s.

According to an Aug. 2020 Nature article, Daszak said the novel coronavirus did not begin in a lab.

However, in a Dec. 9, 2019, just three weeks before the pandemic, in a TWiV video at the 28:10 mark, Daszak said while working on SARS research in the lab setting that the SARS virus can get into human cells.


VIDEO link to interview on TWiV 615 with Dr. Peter Daszak

TWiV 615: Peter Daszak of Eco Health Alliance is interviewed Dec. 9, 2019.


The above contradiction may be a compromise in the investigation and it is further complicated by a Feb. 9, 2021 tweet when Daszak said American Intelligence was not to be trusted about their investigation.

Economically, the investigation is complicated by the National Institute of Health choice to restore Daszak’s multimillion-dollar research and increase it to $7.5 million. The New York Times reported that of the total $123 million in government funding Daszak’s research has received, one third was from the Pentagon.

President Biden chose Jake Sullivan as his National Security Advisor. Sullivan, like Daszak, does not support American Intelligence, according to his interview on CBS Feb. 21, 2021. Sullivan blames Bolton’s dismantling of Ziemer’s military-style consolidated biodefense.

Still, newly unclassified information shows China’s Wuhan Institute of Virology had persons with flu-like illness in the fall of 2019, according to former Asian Affairs director for the National Security Council, Matthew Pottinger, in a Newsmax article.

“If the agency that is doing the oversight is also carrying out the work [research] or funding the work, that is errant conflict of interest. That almost by definition, ensures that the oversight will be lax and that is, of course, what we have currently,” Ebright said.

The truth of origin may not come to light for generations but the facts are that an international biosecurity system should be in place and it is past time to lasso the Wild West of scientific research, but wranglers will need miles of rope.

Because in 2005, the U.S. Government made pharmaceutical companies exempt from liability when creating vaccines during a pandemic. It is not clear if less pressure for the gold standard in meeting FDA requirements led to rushed FDA releases of the trial vaccines and the increase of reported side-effects and vaccinated persons becoming reinfected.

But the drive to create vaccines under federally funded gain-of-function research, like the novel coronavirus, may be why the rush to research while dodging public safety has been trotting along at a steady pace.

The novel coronavirus vaccines are expected to generate billions in 2021. Pfizer is expected to make at least $15 billion in 2021 alone, according to its quarterly report and production agreements. Moderna is expected to make $18.4 billion and Johnson & Johnson is expected to bring in $10 billion, according to their financial reports.

However, hydroxychloroquine costs pennies in comparison and in April 2020, the Association of American Physicians and Surgeons (AAPS) showed evidence of effectiveness.

“The HCQ-AZ combination, when started immediately after diagnosis, appears to be a safe and efficient treatment for COVID-19, with a mortality rate of 0.5% in elderly patients. It avoids worsening and clears virus persistence and contagious infectivity in most cases,” AAPS said.

Besides, Daszak said in the TWiV video that humanized coronaviruses are "untreatable with therapeutic monoclonals [lab-made antibodies] and you can’t vaccinate against them with a vaccine."

In the video, Daszak describes different types of coronaviruses used to make the vaccines for the novel coronavirus. For the average listener, it is not certain which bat coronaviruses are used to make the vaccines.

One thing is certain. Public safety will be at risk until Congress creates international policies that work under a rigid oversight program.


By Stephanie M. Sellers

Journalist

gaumedup@gmail.com



Comments

Popular posts from this blog

Community mourns Cameron, NC's Miss Belle’s Collectibles, Antiques & Tea Room

Donnie Red Hawk McDowell makes Tuscarora History in North Carolina

Guide to Robeson County, NC’s Vernacular